Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
24-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #40381
advertisement
Sun C
63
Showing records 1 to 25 |
Display all abstracts from
Sun C
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Kim S
Ophthalmology science
2024; 4: 100533
117649
The Beijing angle closure progression study: design and methodology
Liang ZQ
Frontiers in medicine
2024; 11: 1385060
117032
A molecular switch for neuroprotective astrocyte reactivity
Cameron EG
Nature
2024; 626: 574-582
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Xue X
Computers in Biology and Medicine
2024; 174: 108399
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
He C
Journal of Neuroinflammation
2024; 21: 43
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Zhang D
Computers in Biology and Medicine
2024; 174: 108399
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Chen V
Ophthalmology science
2024; 4: 100533
117032
A molecular switch for neuroprotective astrocyte reactivity
Nahmou M
Nature
2024; 626: 574-582
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Peng K
Journal of Neuroinflammation
2024; 21: 43
117649
The Beijing angle closure progression study: design and methodology
Yang KY
Frontiers in medicine
2024; 11: 1385060
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Pottenburgh J; Pottenburgh J
Ophthalmology science
2024; 4: 100533
117032
A molecular switch for neuroprotective astrocyte reactivity
Toth AB
Nature
2024; 626: 574-582
117649
The Beijing angle closure progression study: design and methodology
Lv K
Frontiers in medicine
2024; 11: 1385060
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Zhu X
Journal of Neuroinflammation
2024; 21: 43
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Sun C; Shi Y
Computers in Biology and Medicine
2024; 174: 108399
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Wang Z
Journal of Neuroinflammation
2024; 21: 43
117032
A molecular switch for neuroprotective astrocyte reactivity
Heo L
Nature
2024; 626: 574-582
117649
The Beijing angle closure progression study: design and methodology
Ma Y
Frontiers in medicine
2024; 11: 1385060
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Cruz M
Ophthalmology science
2024; 4: 100533
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Wang R
Computers in Biology and Medicine
2024; 174: 108399
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Xiu W
Journal of Neuroinflammation
2024; 21: 43
117649
The Beijing angle closure progression study: design and methodology
Sun C
Frontiers in medicine
2024; 11: 1385060
117032
A molecular switch for neuroprotective astrocyte reactivity
Tanasa B
Nature
2024; 626: 574-582
117681
Netarsudil 0.02% Alters Episcleral Venous Flowrates: A Clinical Trial Using Erythrocyte-Mediated Angiography
Cooper G
Ophthalmology science
2024; 4: 100533
117010
Th1 cells contribute to retinal ganglion cell loss in glaucoma in a VCAM-1-dependent manner
Zhang G
Journal of Neuroinflammation
2024; 21: 43
«
1
2
3
»
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement